Synektik

Synektik Current Liabilities

The Current Liabilities of Synektik (SNT.WA) as of Oct 31, 2026 is 202.97 M PLN. In the previous year, Current Liabilities was 134.65 M PLN — a change of 50.74% (higher).

Current Liabilities

202.97 MPLN

YoY

50.74%

Last updated:

Current Liabilities of Synektik is 2025 202.97 M PLN. Current Liabilities of Synektik was 2024 134.65 M PLN. It decreases by 50.74% higher compared to the previous year.

The Synektik Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
30.17 M PLN
Jan 1, 2019
34.09 M PLN
Jan 1, 2020
36.47 M PLN
Jan 1, 2021
54.98 M PLN
Jan 1, 2022
104.91 M PLN
Jan 1, 2023
118.23 M PLN
Jan 1, 2024
134.65 M PLN
Jan 1, 2025
202.97 M PLN
The Synektik Current Liabilities history
YEARCurrent LiabilitiesYoY
202.97 MPLN+50.74%
134.65 MPLN+13.89%
118.23 MPLN+12.70%
104.91 MPLN+90.80%
54.98 MPLN+50.75%
36.47 MPLN+7.01%
34.09 MPLN+12.98%
30.17 MPLN-25.52%
40.51 MPLN+64.89%
24.57 MPLN-38.32%
39.83 MPLN+1.97%
39.06 MPLN+18.57%
32.94 MPLN+1.90%
32.33 MPLN+53.25%
21.10 MPLN+166.05%
7.93 MPLN-31.64%
11.60 MPLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Synektik Stock analysis

What does Synektik do? Synektik SA generates revenue through its PACS software, which enables diagnostic imaging laboratories to operate efficiently. The company also sells medical equipment and provides services through its imaging equipment services center. Synektik SA partners with Siemens and holds a 100% stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o, which it acquired by raising its stake on November 28, 2013. The firm's research laboratory conducts acceptance and specialist tests on X-ray equipment, contributing to its service offerings. The primary buyers of Synektik SA's products include diagnostic imaging laboratories that require PACS software for their operations. Medical equipment is sold to healthcare facilities, while the research laboratory services are utilized by entities needing X-ray equipment testing. The company's partnership with Siemens supports its medical equipment sales and services. Synektik SA's revenue streams are derived from software licensing, medical equipment sales, and specialized testing services. The company's focus on diagnostic imaging solutions and its ownership of Miedzynarodowe Centra Medyczne Inwestycje Sp z o o position it within the medical technology sector, targeting healthcare providers and imaging laboratories. Synektik is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Synektik stock

Current Liabilities of Synektik is 202.97 M PLN in 2025.

Current Liabilities of Synektik changed from 134.65 M PLN to 202.97 M PLN, representing a 50.74% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Synektik since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Synektik historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Synektik

All Key Metrics — Synektik